Antibiotice Iasi consolidates its financial situation and profitability and enters new export markets
Sănătate
State-controlled company Antibiotice Iasi consolidates its profitability ratio and position on both domestic and international markets, confirming the sustainability of its sustainable and balanced growth strategy. Q1 2025 main economic and financial results , according to the stock exchange announcement: Total revenues: RON 180.03 million; Gross profit: RON 35.34 million, equivalent to a profitability of 21.9%, up 3% compared to Q1 2024; Return on business (gross profit+ claw-back fee) of 27.8%
din zilele anterioare